OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study

Autor: Fátima Cleonice de Souza, Renata Ongaratto, Victória d’A Silveira, Paulo Márcio Pitrez, Frederico Orlando Friedrich, Magáli Mocellin, Marcelo Comerlato Scotta, Leonardo Araújo Pinto, Lidiane Alves de Azeredo Leitão

Publikováno v: Einstein (São Paulo), Volume: 18, Article number: eAO5262, Published: 27 FEB 2020
Einstein (São Paulo), Vol 18 (2020)
Einstein
einstein (São Paulo) v.18 2020
Einstein (São Paulo)
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE

Objective To compare the frequency of respiratory tract infections in children treated with OM-85 BV and placebo during the 3-month therapy period, and observation for a further 3 months after treatment. Methods A randomized, double-blind, placebo-co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4fd40a897fe2b7cddd970b12ad82b3d
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082020000100240&lng=en&tlng=en

[Polysaccharide of Escherichia coli in the Prevention of Recurrent Urinary Tract Infection: An Evidence-Based Review]

Autor: Manuel Tinoco, Mélody Santos, Conceição Reitor, Andreia Rodrigues, João Monteiro

Publikováno v: Acta Médica Portuguesa, Vol 31, Iss 3, Pp 165-169 (2018)

Recurrent urinary tract infection is frequent and it is related to morbidity, costs and growing antibiotic resistance. OM 8930 vaccine is composed by Escherichia coli polysaccharide and it is a possible prophylactic measure, but there is doubt as to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::bd6c486ffe0057aad6d7b991771beb90
https://pubmed.ncbi.nlm.nih.gov/29790468